Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)

Journal of Biological Chemistry

Volumn 290, Issue 4, 2015, Pages 2321-2333

  Song, Woo Joo ^a,c   Song, Eun Ah Christine ^a,c   Jung, Min Su ^c   Choi, Sun Hee ^c   Baik, Hyung Hwan ^a   Jin, Byung Kwan ^a   Kim, Jeong Hee ^b   Chung, Sul Hee ^a,c  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CYTOLOGY; ENZYMES; MAMMALS; NUTRITION; TISSUE;

BIOLOGICAL FUNCTIONS; CONSTITUTIVELY ACTIVES; DIET-INDUCED OBESITY; GLYCOGEN SYNTHASE KINASE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; REGULATORY MECHANISM; TYROSINE PHOSPHORYLATION; WHITE ADIPOSE TISSUES;

PHOSPHORYLATION;

DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 1A; GLYCOGEN SYNTHASE KINASE 3BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN TYROSINE KINASE; THREONINE; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; DYRK KINASE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PROTEIN SERINE THREONINE KINASE; SMALL INTERFERING RNA;

3T3 CELL LINE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; FAT MASS; FEEDING; IMMUNOPRECIPITATION; IN VIVO STUDY; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PLASMID; PROTEIN INTERACTION; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; MALE; METABOLISM; PHOSPHORYLATION;

MUS; MUS MUSCULUS;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOGEN SYNTHASE KINASE 3; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; PHENOTYPE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RNA, SMALL INTERFERING; THREONINE;

EID: 84921789786     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.594952     Document Type: Article

References (37)

1. Stambolic, V., and Woodgett, J. R. (1994) Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation. Biochem. J. 303, 701-704
2. Jope, R. S., and Johnson, G. V. (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci 29, 95-102
3. Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B., and Rincon, M. (2008) Phosphorylation by p38 MAPK as an alternative pathway for GSK3β inactivation. Science 320, 667-670
4. Frame, S., and Cohen, P. (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359, 1-16
5. Doble, B. W., and Woodgett, J. R. (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186
6. Park, J., Song, W. J., and Chung, K. C. (2009) Function and regulation of Dyrk1A: towards understanding Down syndrome. Cell. Mol. Life Sci. 66, 3235-3240
7. Fotaki, V., Dierssen, M., Alcántara, S., Martínez, S., Martí, E., Casas, C., Visa, J., Soriano, E., Estivill, X., and Arbonés, M. L. (2002) Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol. Cell. Biol. 22, 6636-6647
8. Smith, D. J., Stevens, M. E., Sudanagunta, S. P., Bronson, R. T., Makhinson, M., Watabe, A. M., O'Dell, T. J., Fung, J., Weier, H. U., Cheng, J. F., and Rubin, E. M. (1997) Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat. Genet. 16, 28-36
9. Ahn, K. J., Jeong, H. K., Choi, H. S., Ryoo, S. R., Kim, Y. J., Goo, J. S., Choi, S. Y., Han, J. S., Ha, I., and Song, W. J. (2006) DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiol. Dis. 22, 463-472
10. Kimura, R., Kamino, K., Yamamoto, M., Nuripa, A., Kida, T., Kazui, H., Hashimoto, R., Tanaka, T., Kudo, T., Yamagata, H., Tabara, Y., Miki, T., Akatsu, H., Kosaka, K., Funakoshi, E., Nishitomi, K., Sakaguchi, G., Kato, A., Hattori, H., Uema, T., and Takeda, M. (2007) The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between β-amyloid production and Tau phosphorylation in Alzheimer disease. Hum. Mol. Genet. 16, 15-23
11. Ryoo, S. R., Cho, H. J., Lee, H. W., Jeong, H. K., Radnaabazar, C., Kim, Y. S., Kim, M. J., Son, M. Y., Seo, H., Chung, S. H., and Song, W. J. (2008) Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. J. Neurochem. 104, 1333-1344
12. Ryoo, S. R., Jeong, H. K., Radnaabazar, C., Yoo, J. J., Cho, H. J., Lee, H. W., Kim, I. S., Cheon, Y. H., Ahn, Y. S., Chung, S. H., and Song, W. J. (2007) DYRK1A-mediated hyperphosphorylation of Tau: a functional link between Down syndrome and Alzheimer disease. J. Biol. Chem. 282, 34850-34857
13. Ryu, Y. S., Park, S. Y., Jung, M. S., Yoon, S. H., Kwen, M. Y., Lee, S. Y., Choi, S. H., Radnaabazar, C., Kim, M. K., Kim, H., Kim, K., Song, W. J., and Chung, S. H. (2010) Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease. J. Neurochem. 115, 574-584
14. Pearce, N. J., Arch, J. R., Clapham, J. C., Coghlan, M. P., Corcoran, S. L., Lister, C. A., Llano, A., Moore, G. B., Murphy, G. J., Smith, S. A., Taylor, C. M., Yates, J. W., Morrison, A. D., Harper, A. J., Roxbee-Cox, L., Abuin, A., Wargent, E., and Holder, J. C. (2004) Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3β on a muscle-specific promoter. Metabolism 53, 1322-1330
15. Park, J. H., Jung, M. S., Kim, Y. S., Song, W. J., and Chung, S. H. (2012) Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11α. J. Neurochem. 122, 1081-1091
16. Jung, M. S., Park, J. H., Ryu, Y. S., Choi, S. H., Yoon, S. H., Kwen, M. Y., Oh, J. Y., Song, W. J., and Chung, S. H. (2011) Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation. J. Biol. Chem. 286, 40401-40412
17. Lee, H., Lee, Y. J., Choi, H., Ko, E. H., and Kim, J. W. (2009) Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J. Biol. Chem. 284, 10601-10609
18. Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., and Pearl, L. H. (2001) Crystal structure of glycogen synthase kinase 3β: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732
19. Zheng-Fischhöfer, Q., Biernat, J., Mandelkow, E. M., Illenberger, S., Godemann, R., and Mandelkow, E. (1998) Sequential phosphorylation of Tau by glycogen synthase kinase-3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur. J. Biochem. 252, 542-552
20. Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P., and Crabtree, G. R. (1997) Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275, 1930-1934
21. Arron, J. R., Winslow, M. M., Polleri, A., Chang, C. P., Wu, H., Gao, X., Neilson, J. R., Chen, L., Heit, J. J., Kim, S. K., Yamasaki, N., Miyakawa, T., Francke, U., Graef, I. A., and Crabtree, G. R. (2006)NFATdysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441, 595-600
22. Kurabayashi, N., Hirota, T., Sakai, M., Sanada, K., and Fukada, Y. (2010) DYRK1A and glycogen synthase kinase 3β, a dual-kinase mechanism directing proteasomal degradation of CRY2 for circadian timekeeping. Mol. Cell. Biol. 30, 1757-1768
23. Woods, Y. L., Cohen, P., Becker, W., Jakes, R., Goedert, M., Wang, X., and Proud, C. G. (2001) The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bε at Ser539 and the microtubule-associated protein Tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem. J. 355, 609-615
24. Hong, S. H., Lee, K. S., Kwak, S. J., Kim, A. K., Bai, H., Jung, M. S., Kwon, O. Y., Song, W. J., Tatar, M., and Yu, K. (2012) Minibrain/Dyrk1a regulates food intake through the Sir2-FOXO-sNPF/NPY pathway in Drosophila and mammals. PLOS Genet. 8, e1002857
25. Lee, S., Yang, W. K., Song, J. H., Ra, Y. M., Jeong, J. H., Choe, W., Kang, I., Kim, S. S., and Ha, J. (2013) Anti-obesity effects of 3-hydroxychromone derivative, a novel small-molecule inhibitor of glycogen synthase kinase-3. Biochem. Pharmacol. 85, 965-976
26. Chang, S., Graham, B., Yakubu, F., Lin, D., Peters, J. C., and Hill, J. O. (1990) Metabolic differences between obesity-prone and obesity-resistant rats. Am. J. Physiol. 259, R1103-R1110
27. Sutherland, C., Leighton, I. A., and Cohen, P. (1993) Inactivation of glycogen synthase kinase-3β by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 296, 15-19
28. Ding, Q., Xia, W., Liu, J. C., Yang, J. Y., Lee, D. F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., Bargou, R. C., Qin, J., Lai, C. C., Tsai, F. J., Tsai, C. H., and Hung, M. C. (2005) Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin. Mol. Cell. 19, 159-170
29. Eldar-Finkelman, H., Schreyer, S. A., Shinohara, M. M., LeBoeuf, R. C., and Krebs, E. G. (1999) Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 48, 1662-1666
30. Bennett, C. N., Ross, S. E., Longo, K. A., Bajnok, L., Hemati, N., Johnson, K. W., Harrison, S. D., and MacDougald, O. A. (2002) Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. J. Biol. Chem. 277, 30998-31004
31. Steuber-Buchberger, P., Wurst, W., and Kühn, R. (2008) Simultaneous Cre-mediated conditional knockdown of two genes in mice. Genesis 46, 144-151
32. Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L., and MacDougald, O. A. (2000) Inhibition of adipogenesis by Wnt signaling. Science 289, 950-953
33. MacAulay, K., Blair, A. S., Hajduch, E., Terashima, T., Baba, O., Sutherland, C., and Hundal, H. S. (2005) Constitutive activation of GSK3 downregulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells. J. Biol. Chem. 280, 9509-9518
34. Rachdi, L., Kariyawasam, D., Guez, F., Aïello, V., Arbonés, M. L., Janel, N., Delabar, J. M., Polak, M., and Scharfmann, R. (2014) Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic β cell mass. Diabetologia 57, 960-969
35. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P., and Auwerx, J. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127, 1109-1122
36. Guo, X., Williams, J. G., Schug, T. T., and Li, X. (2010) DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. J. Biol. Chem. 285, 13223-13232
37. Yang, T. T., Suk, H. Y., Yang, X., Olabisi, O., Yu, R. Y., Durand, J., Jelicks, L. A., Kim, J. Y., Scherer, P. E., Wang, Y., Feng, Y., Rossetti, L., Graef, I. A., Crabtree, G. R., and Chow, C. W. (2006) Role of transcription factorNFAT in glucose and insulin homeostasis. Mol. Cell. Biol. 26, 7372-7387